Search

everythinglearnresearchcommunity

for

Search:↓

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

CD2 might be a new treatment target for patchy alopecia areata.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

ILC1 cells contribute to hair loss in alopecia areata.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Burn scars form abnormally due to changes in wound healing, and more research is needed to improve treatments.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Eating shiitake mushrooms caused a man to develop a rash similar to a skin condition known as AGEP.

Blood stem cells are diverse, influenced by many factors, and understanding them is key for progress in regenerative medicine.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Blood-derived CD34+ cells speed up healing, reduce scarring, and regrow hair in skin wounds.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Certain gene variations may increase the risk and severity of alopecia areata.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Lack of Cisd2 disrupts calcium balance in cells, leading to poorly functioning neutrophils.

The model helps understand alopecia areata and suggests ways to improve treatment by targeting immune issues.